Access to Cancer Clinical Trials Act of 2009

Health care reform (H.R. 3590, H.R. 3962, H.R. 4872); access to clinical trials (H.R. 716, S. 488)

Client expense: Not reported · Firm income: $100,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 2366 Cancer Coverage Parity Act of 2009 S. 488/H.R. 716 - Access to Cancer Clinical Trials Act of 2009 H.RES.1433 - Designation of September 2010 as Blood Cancer Awareness Month S. 717/ H.R. 6224 - 21st Century Cancer ALERT Act S.3697 - Creating Hope Act of 2010

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the prevention and treatment of lung disease including the following legislation:HR 1619 Children's Health Protection Act of 2009; HR 716 Access to Cancer Clinical Trials Act; S. 488 Access to Cancer Clinical Trials Act; HR 1850 Quit Smoking for Life Act; S. 770 Medicare, Medicaid, and MCH Tobacco Cessation Promotion Act of 2009; S. 717 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act; HR 332 Lung Cancer Mortality Reduction Act of 2009; HR 2112 Lung Cancer Mortality Reduction Act of 2009; S. 670 Smoke Free Mothers and Babies Act of 2009; HR 3200: America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act; S.1796 Americas Healthy Future Act of 2009; HR 3590 The Patient Protection and Affordable Care Act; H.R. 3220 Medicare Home Oxygen Therapy Act of 2009; HR 3790 To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner; H.R.4872 Health Care and Education Reconciliation Act of 2010; Issues related to asthma; Issues related to chronic obstructive pulmonary disease; Issues related to lung cancer; Issues related to tuberculosis; Issues related to durable medical equipment; Issues related to pulmonary rehabilitation services; Issues related to influenza; Issues related to tobacco cessation services; Issues related to the implementation of the Patient Protection and Affordable Care Act;

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Postal Regulatory Commission, SENATE, U.S. Postal Service (USPS), U.S. Trade Representative (USTR), White House Office

Issues related to the prevention and treatment of lung disease, including the following legislation: HR 1619 Children's Health Protection Act of 2009; S 643 Children's Health Protection Act of 2009; HR 716 Access to Cancer Clinical Trials Act; S. 488 Access to Cancer Clinical Trials Act; HR 1850 Quit Smoking for Life Act; S. 770 Medicare, Medicaid, and MCH Tobacco Cessation Promotion Act of 2009; S. 717 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act S. 332 Lung Cancer Mortality Reduction Act of 2009; HR 2112 Lung Cancer Mortality Reduction Act of 2009; S 670 Smoke Free Mothers and Babies Act of 2009; S.914 Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009; HR 1079 Pulmonary Fibrosis Research Enhancement Act; HR 2730 Student-to-School Nurse Ratio Improvement Act of 2009; HR 3293 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010; HR 3200: America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act; S.1796 Americas Healthy Future Act of 2009; HR 3590 The Patient Protection and Affordable Care Act; S. 1577 The Asthma Act; H.R. 3220 Medicare Home Oxygen Therapy Act of 2009; HR 2293 The Public Health Trade Advisory Committee Act; S. 1760 Family Asthma Act; HR 3754 Family Asthma Act; H.Res 919 Supporting the goals and ideals of Chronic Obstructive Pulmonary Disease Awareness Month; S. 2817 A bill to amend part D of title V of the Elementary and Secondary Education Act of 1965 to provide grants to schools for the development of asthma management plans and the purchase of asthma inhalers and spacers for emergency use, as necessary; P.L. 110-233, Genetic Information Nondescrimination Act; HR 3790 To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner; H.R.4872 Health Care and Education Reconciliation Act of 2010; Issues related to asthma; Issues related to chronic obstructive pulmonary disease; Issues related to lung cancer; Issues related to tuberculosis; Issues related to nicotine drug delivery devices; Issues related to drug safety; Issues related to durable medical equipment; Issues related to pulmonary rehabilitation services; Issues related to influenza; Issues related to genetic non-discrimination; Issues related to tobacco strategic plan; Issues related to prevention and wellness. Issues related to the implementation of the Patient Protection and Affordable Care Act; H.R.5297 Small Business Jobs and Credit Act of 2010

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Postal Regulatory Commission, SENATE, U.S. Postal Service (USPS), U.S. Trade Representative (USTR), White House Office

Health care reform (H.R. 3590, H.R. 3962, H.R. 4872); access to clinical trials (H.R. 716, S. 488)

Client expense: Not reported · Firm income: $100,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Healthcare for cancer patients , C.W. Bill Young Transplatation Program, National Cord Blood Inventory, H.R. 1230 Bone Marrow Failure Disease Research and Treatment Act of 2009, S 488, H.R. 716, Access to Cancer Clinical Trials Act of 2009, SGW 121 access to all healthcare bill, SRES 205/HCR 150 African American Bone Marrow Awareness month, Americans Affordable Health Choices Act of 2009, American Healthy Future Act of 2009, H.R.6081 and S.3751, The Stem Cell Therapeutic & Research Act 2010 HR 1230

Client expense: $98,624 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Tax Credits for Cord Blood Donations-Donor Related Expenses, HR 716,HR 1654, HR 1718

Client expense: $98,624 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

S. 488/H.R. 716 - Access to Cancer Clinical Trials Act of 2009; H.R. 1189 - Colorectal Cancer Prevention, Early Detection, and Treatment Act of 2009; H.R. 1330 - Colorectal Cancer Screening and Detection Coverage Act of 2009; H.R. 756/S. 660 - National Pain Policy Act of 2009; S. 497/H.R. 2043 - Nurse Education, Expansion, and Development Act of 2009; Health Reform; Health Workforce Shortage Issues; S. 623/H.R. 1558 - Preexisting Condition Exclusion Patient Protection Act of 2009; (Continued) S. 643/H.R. 1619 - Children's Health Protection Act of 2009; S. 688/H.R. 1691 - Breast Cancer Patient Protection Act; H.R. 2366 - Cancer Drug Coverage Parity Act; FDA Regulation of Opioids; H.R. 2115- Men and Familes Health Care Act; Health Care Reform; H.R. 3962 - Affordable Health Care for America Act; H.R. 3590 - Patient Protection and Affordable Care Act; H.R. 4872 - Reconciliation Act of 2010.

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office

H.R. 2366 Cancer Coverage Parity Act of 2009 S. 488/H.R. 716 - Access to Cancer Clinical Trials Act of 2009 S. 717 - 21st Century Cancer ALERT Act H.RES.1433 - Designation of September 2010 as Blood Cancer Awareness Month

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for the Access to Cancer Clinical Trials Act of 2009 (S. 488, H.R. 716) to provide access to clinical trials for cancer patients. Support for health care reform provisions in the America's Healthy Future Act (H.R. 3200), the Patient Protection and Affordable Care Act (H.R. 3590), and the Affordable Health Choices Act (S. 1796) to reform health care through a combination of public and private approaches to cover medically necessary services; support review and development of national workforce strategy; support elimination of pre-existing condition limitations; support medical liability reform; support consumer protection from annual and lifetime insurance limits; provide funding for comparative effectiveness research; and support expanded access to and use of regular health assessments and preventive services, including early screening and detection. Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for the development of domestic medical isotope production, specifically American Medical Isotope Production Act of 2010 (H.R. 3276). Support for national reporting database of medical errors related to the delivery of radiation therapy.

Client expense: $240,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE

Matters related to health care reform: H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, Health Care and Education Affordability Reconciliation Act, implementation of patient protections, appointments to advisory boards; Matters related to appropriations for cancer research and cancer control programs. Also H.R. 1740/S. 994, Breast Cancer Education and Awareness Requires Learning Young Act; H.R. 716/S. 488, Access to Cancer Clinical Trials Act; S. 717, 21st Century Cancer ALERT Act.

Client expense: $310,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to the prevention and treatment of lung disease including the following legislation:HR 1619 Children's Health Protection Act of 2009; HR 716 Access to Cancer Clinical Trials Act; S. 488 Access to Cancer Clinical Trials Act; HR 1850 Quit Smoking for Life Act; S. 770 Medicare, Medicaid, and MCH Tobacco Cessation Promotion Act of 2009; S. 717 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act; HR 332 Lung Cancer Mortality Reduction Act of 2009; HR 2112 Lung Cancer Mortality Reduction Act of 2009; S. 670 Smoke Free Mothers and Babies Act of 2009; HR 3200: America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act; S.1796 Americas Healthy Future Act of 2009; HR 3590 The Patient Protection and Affordable Care Act; H.R. 3220 Medicare Home Oxygen Therapy Act of 2009; HR 3790 To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner; H.R.4872 Health Care and Education Reconciliation Act of 2010; Issues related to asthma; Issues related to chronic obstructive pulmonary disease; Issues related to lung cancer; Issues related to tuberculosis; Issues related to durable medical equipment; Issues related to pulmonary rehabilitation services; Issues related to influenza; Issues related to tobacco cessation services; Issues related to the implementation of the Patient Protection and Affordable Care Act;

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Postal Regulatory Commission, SENATE, U.S. Postal Service (USPS), U.S. Trade Representative (USTR), White House Office

Issues related to the prevention and treatment of lung disease, including the following legislation: HR 1619 Children's Health Protection Act of 2009; S 643 Children's Health Protection Act of 2009; HR 716 Access to Cancer Clinical Trials Act; S. 488 Access to Cancer Clinical Trials Act; HR 1850 Quit Smoking for Life Act; S. 770 Medicare, Medicaid, and MCH Tobacco Cessation Promotion Act of 2009; S. 717 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act S. 332 Lung Cancer Mortality Reduction Act of 2009; HR 2112 Lung Cancer Mortality Reduction Act of 2009; S 670 Smoke Free Mothers and Babies Act of 2009; S.914 Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009; HR 1079 Pulmonary Fibrosis Research Enhancement Act; HR 2730 Student-to-School Nurse Ratio Improvement Act of 2009; HR 3293 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010; HR 3200: America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act; S.1796 Americas Healthy Future Act of 2009; HR 3590 The Patient Protection and Affordable Care Act; S. 1577 The Asthma Act; H.R. 3220 Medicare Home Oxygen Therapy Act of 2009; HR 2293 The Public Health Trade Advisory Committee Act; S. 1760 Family Asthma Act; HR 3754 Family Asthma Act; H.Res 919 Supporting the goals and ideals of Chronic Obstructive Pulmonary Disease Awareness Month; S. 2817 A bill to amend part D of title V of the Elementary and Secondary Education Act of 1965 to provide grants to schools for the development of asthma management plans and the purchase of asthma inhalers and spacers for emergency use, as necessary; P.L. 110-233, Genetic Information Nondescrimination Act; HR 3790 To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner; H.R.4872 Health Care and Education Reconciliation Act of 2010; Issues related to asthma; Issues related to chronic obstructive pulmonary disease; Issues related to lung cancer; Issues related to tuberculosis; Issues related to nicotine drug delivery devices; Issues related to drug safety; Issues related to durable medical equipment; Issues related to pulmonary rehabilitation services; Issues related to influenza; Issues related to genetic non-discrimination; Issues related to tobacco strategic plan; Issues related to prevention and wellness.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Postal Regulatory Commission, SENATE, U.S. Postal Service (USPS), U.S. Trade Representative (USTR), White House Office

S. 488/H.R. 716 - Access to Cancer Clinical Trials Act of 2009; H.R. 1189 - Colorectal Cancer Prevention, Early Detection, and Treatment Act of 2009; H.R. 1330 - Colorectal Cancer Screening and Detection Coverage Act of 2009; H.R. 756/S. 660 - National Pain Policy Act of 2009; S. 497/H.R. 2043 - Nurse Education, Expansion, and Development Act of 2009; Health Reform; Health Workforce Shortage Issues; S. 623/H.R. 1558 - Preexisting Condition Exclusion Patient Protection Act of 2009; (Continued) S. 643/H.R. 1619 - Children's Health Protection Act of 2009; S. 688/H.R. 1691 - Breast Cancer Patient Protection Act; H.R. 2366 - Cancer Drug Coverage Parity Act; FDA Regulation of Opioids; H.R. 2115- Men and Familes Health Care Act; Health Care Reform; H.R. 3962 - Affordable Health Care for America Act; H.R. 3590 - Patient Protection and Affordable Care Act; H.R. 4872 - Reconciliation Act of 2010.

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office

S. 717, 21st Century Cancer Access to Learning, Education, Research and Treatment (ALERT) Act H.R. 1740, Breast Cancer Education and Awareness Requires Learning Young (EARLY) Act of 2009 H.R. 716/ S. 488 Access to Cancer Clinical Trials Act Matters pertaining to healthcare reform legislation Health care reform: H.R. 3590 Patient Protection and Affordable Care Act and H.R. 3962 Affordable Health Care for America Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Healthcare for cancer patients, C.W. Bill Young Transplantation Program, National Cord Blood Inventory, H.R. 1230 Bone Marrow Failure Disease Research and Treatment Act of 2009, S 488, H.R. 716, Access to Cancer Clinical Trials Act of 2009, SGW 121 access to all healthcare bill, SRES 205/HCR 150 African American Bone Marrow Awareness Month, Americans Affordable Health Choices Act of 2009, American Healthy Future Act of 2009

Client expense: $115,663 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Tax Credits for Cord Blood Donations-Donor Related Expenses, HR 716, HR 1654, HR 1718

Client expense: $115,663 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Health care reform (H.R. 3590, H.R. 3962, H.R. 4872); acces to clinical trials (H.R. 716, S. 488)

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2366 Cancer Coverage Parity Act of 2009 S. 488/H.R. 716 - Access to Cancer Clinical Trials Act of 2009 S. 717 - 21st Century Cancer ALERT Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3590, Patient Protection and Affordable Care Act and H.R. 3962, Affordable Health Care for America Act, provisions on: patient protections, including protections from pre-existing conditions and out-of-pocket expenditures; clinical trials coverage; patient navigations; and breast health for young women; H.R. 1704/S. 994, Breast Cancer Education and Awareness Requires Learning Young Act; H.R. 716/S. 488, Access to Cancer Clinical Trials Act; S. 717, 21st Century Cancer ALERT Act.

Client expense: $100,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Health & Human Services, Dept of (HHS), SENATE

H.R. 716, Access to Cancer Clinical Trials Act (Israel) clinical trials coverage mandate; H.R. 850, Small Business CHOICE Act (Velazquez) small employer health options; H.R. 859, Small Business CHOICE Act (Velazquez) small employer health options; (cont.) INS (Legislative) H.R. 1085, Health Insurance Coverage Protection Act (Eshoo) lifetime benefit limits; H.R. 1092, No Discrimination in Health Insurance Act (Kagen) preexisting condition exclusions, affiliation periods, uniform premiums; H.R. 1253, Health Insurance Restrictions and Limitations Clarification Act (Burgess) disclosure of coverage exclusions; H.R. 1321, Healthy Americans Act (Eshoo) comprehensive health reform; H.R. 1558, Preexisting Condition Patient Protection Act (Courtney) preexisting condition exclusions; H.R. 1583, Insurance Industry Competition Act (DeFazio) McCarran Ferguson reforms; H.R. 1619, Children's Health Protection Act (Schwartz) preexisting condition exclusions for children; H.R. 1691, Breast Cancer Patient Protection Act (DeLauro) rescissions, hospital stays for breast cancer patients; H.R. 1721, CLASS Act (Pallone) national LTC program; H.R. 1880, National Insurance Consumer Protection Act (Bean) regulatory reform; H.R. 2360, SHOP Act (Kind) small employer health options; H.R. 2402, Woman's Health Insurance Fairness Act (Neal) gender rating for health insurance; H.R. 2413, Autism Treatment Acceleration Act (Doyle) coverage for autism spectrum disorders; H.R. 2427, Informed Consumer Choices in Health Care Act (DeLauro) federal standards for health insurance, consumer information; H.R. 2457, Right to a Second Medical Opinion Act (Davis) coverage of second opinions; H.R. 2609, Insurance Information Act (Kanjorski) Federal Office of Insurance Information; H.R. 2635, Gender Equity in Health Premiums Act (Sanchez) gender rating for health insurance; H.R. 2833, Medical Loss Ratios (Ellison) medical loss ratios; H.R. 2940, Women's Obstetrician and Gynecologist Medical Access Now Act (Davis) direct access to ob/gyns; H.R. 3200, Americas Affordable Health Choices Act (Dingell) government-run health plan, health insurance exchange, regulatory reform, health choices commissioner, insurance market reforms, individual coverage requirement, benefit packages, CLASS Act, medical loss ratios, premium assistance; H.R. 3217, Health Care Choice Act (Shadegg) national marketplace; H.R. 3584, Health Care Consumer Protection Act (Forbes) reinstatement of coverage upon payment of overdue premiums; H.R. 3590, Patient Protection and Affordable Care Act (Reid) government-run health plan, health insurance cooperatives, multi-state plans, insurance market reforms, health insurance exchanges, benefit packages, medical loss ratios, CLASS Act, regulatory reform, individual coverage requirement, premium assistance, federal rate review process, health care choice compacts, appeals procedures, disclosure requirements, high risk pool program, McCarran-Ferguson Act; H.R. 3596, Health Insurance Industry Antitrust Enforcement Act (Conyers) changes to McCarran-Ferguson Act; H.R.3681, Fairness in Health Insurance Act (Ellison) medical loss ratios; H.R. 3962, Americas Affordable Health Choices Act (Dingell) government-run health plan, health insurance exchange, regulatory reform, health choices commissioner, insurance market reforms, individual coverage requirement, benefit packages, CLASS Act, medical loss ratios, premium assistance, federal rate review process, health care choice compacts, high risk pool program, McCarran-Ferguson Act; H.R. 4078, Long-Term Care Insurance Disclosure Act (Perriello) model disclosure form for long-term care insurance; H.R. 4563, Cancer Screening Coverage Act (Maloney) coverage requirement for cancer screening; H.R. 4626, Health Insurance Industry Fair Competition Act (Perriello) McCarran-Ferguson antitrust exemption; H.R. 4757, Health Insurance Rate Authority Act (Schakowsky) federal rate review process; H.R. 4872, Health Care and Education Reconciliation Act (Spratt) changes to individual coverage requirement, grandfathered plans, immediate insurance reforms, premium assistance, CLASS Act, coverage issues, quality improvements, delivery system reforms; S. 79, Healthy Businesses, Healthy Workers Reinsurance Act (Kerry) reinsurance; S. 93, Small Business Empowerment Act (Brown) small employer health options; S. 391, Healthy Americans Act (Wyden) comprehensive health reform; S. 442, Health Insurance Coverage Protection Act (Dorgan) lifetime benefit limits; S. 488, Access to Cancer Clinical Trials Act (Brown) clinical trials coverage mandate; S. 623, Pre-existing Condition Patient Protection Act (Rockefeller) preexisting condition exclusions; S. 643, Children's Health Protection Act (Lautenberg) preexisting condition exclusions for children; S. 688, Breast Cancer Patient Protection Act (Snowe) rescissions, hospital stays for breast cancer patients; S. 697, CLASS Act (Kennedy) national LTC program; S. 819, Autism Treatment Acceleration Act (Durbin) coverage for autism spectrum disorders; S. 969, Women's Health Insurance Fairness Act (Kerry) gender rating for health insurance; S. 979, SHOP Act (Durbin) small employer health options; S. 1050, Informed Consumer Choices in Health Care Act (Rockefeller) federal standards for health insurance, consumer information; S. 1149, Annual and Lifetime Health Care Limit Elimination Act (Rockefeller) annual and lifetime coverage limits; S. 1177, Confidence in Long-Term Care Insurance Act (Kohl) LTC consumer protections; (cont.) INS (Legislative) S. 1459, Health Care Choice Act (DeMint) national marketplace; S. 1626, Long Term Care Insurance Integrity Act (Klobuchar) third party review of LTCI disputed claims; S. 1636, Long-Term Care Insurance Consumer Right-to-Know Act (Klobuchar) model disclosure forms for LTC insurance; S. 1679, Affordable Health Choices Act (Harkin) government-run health plan, insurance market reforms, health benefit gateways, benefit packages, medical loss ratios, CLASS Act, regulatory reform, individual coverage requirement, premium assistance; S. 1681, Health Insurance Industry Antitrust Enforcement Act (Leahy) changes to McCarran-Ferguson Act; S. 1730, Fairness in Health Insurance Act (Franken) medical loss ratios; S. 1796, Americas Healthy Future Act (Baucus) government-run health plan, health insurance cooperatives, health insurance exchange, insurance market reforms, individual coverage requirement, benefit packages, premium assistance, medical loss ratios, regulatory reform; S. 3078, Health Insurance Rate Authority Act (Feinstein) federal rate review process INS (Regulatory) Insurance regulatory reform; issues related to the coordination of private and public disability income benefits; disability risk management; issues relating to the coordination of benefits between private health insurance plans and Medicaid; Medigap claims processing and crossover fees; implementation of Medigap standardized plan offerings; Medigap carrier recoveries related to CMS fraud and abuse enforcement activities, and issues related to Medigap educational materials; implementation of the Mental Health Parity Act requirements; issues related to COBRA subsidy requirements, and issues related to genetic nondiscrimination.

Client expense: $2,700,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of

Issues related to the prevention and treatment of lung disease including the following legislation:HR 1619 Children's Health Protection Act of 2009; HR 716 Access to Cancer Clinical Trials Act; S. 488 Access to Cancer Clinical Trials Act; HR 1850 Quit Smoking for Life Act; S. 770 Medicare, Medicaid, and MCH Tobacco Cessation Promotion Act of 2009; S. 717 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act; HR 332 Lung Cancer Mortality Reduction Act of 2009; HR 2112 Lung Cancer Mortality Reduction Act of 2009; S. 670 Smoke Free Mothers and Babies Act of 2009; HR 3200: America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act; S.1796 Americas Healthy Future Act of 2009; HR 3590 The Patient Protection and Affordable Care Act; H.R. 3220 Medicare Home Oxygen Therapy Act of 2009; HR 3790 To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner; H.R.4872 Health Care and Education Reconciliation Act of 2010; Issues related to asthma; Issues related to chronic obstructive pulmonary disease; Issues related to lung cancer; Issues related to tuberculosis; Issues related to durable medical equipment; Issues related to pulmonary rehabilitation services; Issues related to influenza; Issues related to tobacco cessation services.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office

Issues related to the prevention and treatment of lung disease, including the following legislation: HR 1619 Children's Health Protection Act of 2009; S 643 Children's Health Protection Act of 2009; HR 716 Access to Cancer Clinical Trials Act; S. 488 Access to Cancer Clinical Trials Act; HR 1850 Quit Smoking for Life Act; S. 770 Medicare, Medicaid, and MCH Tobacco Cessation Promotion Act of 2009; S. 717 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act S. 332 Lung Cancer Mortality Reduction Act of 2009; HR 2112 Lung Cancer Mortality Reduction Act of 2009; S 670 Smoke Free Mothers and Babies Act of 2009; S.914 Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009; HR 1079 Pulmonary Fibrosis Research Enhancement Act; HR 2730 Student-to-School Nurse Ratio Improvement Act of 2009; HR 3293 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010; HR 3200: America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act; S.1796 Americas Healthy Future Act of 2009; HR 3590 The Patient Protection and Affordable Care Act; S. 1577 The Asthma Act; H.R. 3220 Medicare Home Oxygen Therapy Act of 2009; HR 2293 The Public Health Trade Advisory Committee Act; S. 1760 Family Asthma Act; HR 3754 Family Asthma Act; H.Res 919 Supporting the goals and ideals of Chronic Obstructive Pulmonary Disease Awareness Month; S. 2817 A bill to amend part D of title V of the Elementary and Secondary Education Act of 1965 to provide grants to schools for the development of asthma management plans and the purchase of asthma inhalers and spacers for emergency use, as necessary; P.L. 110-233, Genetic Information Nondescrimination Act; HR 3790 To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner; H.R.4872 Health Care and Education Reconciliation Act of 2010; Issues related to asthma; Issues related to chronic obstructive pulmonary disease; Issues related to lung cancer; Issues related to tuberculosis; Issues related to nicotine drug delivery devices; Issues related to drug safety; Issues related to durable medical equipment; Issues related to pulmonary rehabilitation services; Issues related to influenza; Issues related to genetic non-discrimination; Issues related to tobacco strategic plan; Issues related to prevention and wellness.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office

All matters pertaining to breast cancer issues in the budget S. 717, 21st Century Cancer Access to Learning, Education, Research and Treatment (ALERT) Act H.R. 1740, Breast Cancer Education and Awareness Requires Learning Young (EARLY) Act of 2009 H.R. 716/S. 488 Access to Cancer Clinical Trials Act Matters pertaining to health care reform legislation Health care reform: H.R. 3590 Patient Protection and Affordable Care Act and H.R. 3962, Affordable Health Care for America Act.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Tax credits for Cord Blood donations-donor related expenses, HR 716, HR 1654, HR 1718

Client expense: $120,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Healthcare for Cancer patients, C.W. Bill Young Transplantation Program, National Cord Blood Inventory, H.R. 1230 Bone Marrow Failure Disease Research and Treatment Act of 2009, S. 488, H.R. 716, Access to Cancer Clinical Trials Act of 2009, SGW 121 access to all healthcare bill, SRES 205/HCR 150 African American Bone Marrow Awareness Month, Americans Affordable Health Choices Act of 2009, American Healthy Future Act of 2009.

Client expense: $120,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

H.R. 716, S.488 - Access to Cancer Clinical Trials Act H.R. 3200 - America's Affordable Health Choices Act of 2009 S. 1679 - Affordable Health Choices Act S. 1796 - America's Healthy Future Act of 2009 H.R. 3134 - Healthcare Innovation Zone Program Act of 2009 H.R. 3962 - Affordable Health Care for America Act H.R. 3590 - Patient Protection and Affordable Care Act

Client expense: $100,000 · Firm income: Not reported

Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE

Health care reform (H.R. 3590, H.R. 3962, H.R. 4872); access to clinical trials (H.R. 716, S. 488)

Client expense: Not reported · Firm income: $90,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 488/H.R. 716 - Access to Cancer Clinical Trials Act of 2009; H.R. 1189 - Colorectal Cancer Prevention, Early Protection, and Treatment Act of 2009; H.R. 1330 - Colorectal Cancer Screening and Detection Coverage Act of 2009; H.R. 756/S. 660 - National Pain Policy Act of 2009; S. 497/H.R. 2043 - Nurse Education, Expansion, and Development Act of 2009; Health Reform; Health Workforce Shortage Issues; S. 623/H.R. 1558 - Preexisting Condition Exclusion Patient Protection Act of 2009; (Continued) S. 643/H.R. 1619 - Children's Health Protection Act of 2009; S. 688/H.R. 1691 - Breast Cancer Patient Protection Act; H.R. 2366 - Cancer Drug Coverage Parity Act; FDA Regulation of Opioids; H.R. 2115- Men and Familes Health Care Act; Health Care Reform; H.R. 3962 - Affordable Health Care for America Act; H.R. 3590 - Patient Protection and Affordable Care Act; H.R. 4872 - Reconciliation Act of 2010.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office

Support for the Access to Cancer Clinical Trials Act of 2009 (S. 488, H.R. 716) to provide access to clinical trials for cancer patients. Support for health care reform provisions in the America's Healthy Future Act (H.R. 3200), the Patient Protection and Affordable Care Act (H.R. 3590), and the Affordable Health Choices Act (S. 1796) to reform health care through a combination of public and private approaches to cover medically necessary services; support review and development of national workforce strategy; support elimination of pre-existing condition limitations; support medical liability reform; support consumer protection from annual and lifetime insurance limits; provide funding for comparative effectiveness research; and support expanded access to and use of regular health assessments and preventive services, including early screening and detection. Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for the development of domestic medical isotope production, specifically American Medical Isotope Production Act of 2010 (H.R. 3276). Support for national reporting database of medical errors related to the delivery of radiation therapy.

Client expense: $240,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE

Support S. 717, the 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act; support H.R. 3962, the Affordable Health Care for America Act/H.R. 3590, the Patient Protection and Affordable Care Act, as it relates to breast cancer prevention, screening, research, and treatment; support H.R. 1740, the Breast Cancer Education and Awareness Requires Learning Young Act of 2009; support H.R. 716/S. 488, Access to Cancer Clinical Trials Act of 2009.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Urging Members to support H.R.716 Access to Cancer Clinical Trials Act of 2009; Urging for Mental Illness and Substance Abuse Parity

Client expense: $10,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

S. 488/H.R. 716, Access to Cancer Clinical Trials Act, seeking cosponsors H.R. 1844, Comprehensive Cancer Care Improvement Act, seeking cosponsors H.R. 3590, The Patient Protection and Affordable Care Act, seeking support for the clinical trials amendment

Client expense: $13,089 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

NIH / NCI Appropriations DoD Appropriations - Cancer Research Programs Clinical Trials Legislation - H.R. 716 & S. 488

Client expense: $40,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Personnel Management (OPM), SENATE

H.R. 2366 Cancer Coverage Parity Act of 2009 S. 488/H.R. 716 - Access to Cancer Clinical Trials Act of 2009 S. 717 - 21st Century Cancer ALERT Act H.R. 3200 - America's Affordable Health Choices Act of 2009 S. 1796 - America's Healthy Future Act of 2009

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 323, Comprehensive Insurance Coverage of Childhood Immunization Act (Green) immunization coverage mandate; H.R. 584, Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act (Lee) coverage mandate for hormone replacement therapy (cont.) H.R. 697, Family Building Act (Weiner) coverage mandate for infertility treatments; H.R. 716, Access to Cancer Clinical Trials Act (Israel) clinical trials coverage mandate; H.R. 850, Small Business CHOICE Act (Velazquez) small employer health options; H.R. 859, Small Business CHOICE Act (Velazquez) small employer health options; H.R. 995, Mammogram and MRI Availability Act (Nadler) coverage mandate for mammograms; H.R. 1085, Health Insurance Coverage Protection Act (Eshoo) lifetime benefit limits; H.R. 1092, No Discrimination in Health Insurance Act (Kagen) preexisting condition exclusions, affiliation periods, uniform premiums; H.R. 1253, Health Insurance Restrictions and Limitations Clarification Act (Burgess) disclosure of coverage exclusions; H.R. 1321, Healthy Americans Act (Eshoo) comprehensive health reform; H.R. 1330, Colorectal Cancer Screening and Detection Coverage Act (Boren) coverage mandate for cancer screening; H.R. 1339, Children's Access to Reconstructive Evaluation & Surgery Act (McCarthy) coverage mandate for treatment of a child's congenital or developmental deformity; H.R. 1558, Preexisting Condition Patient Protection Act (Courtney) preexisting condition exclusions; H.R. 1583, Insurance Industry Competition Act (DeFazio) McCarran Ferguson reforms; H.R. 1619, Children's Health Protection Act (Schwartz) preexisting condition exclusions for children; H.R. 1691, Breast Cancer Patient Protection Act (DeLauro) rescissions, hospital stays for breast cancer patients; H.R. 1721, CLASS Act (Pallone) national LTC program; H.R. 1880, National Insurance Consumer Protection Act (Bean) regulatory reform; H.R. 2360, SHOP Act (Kind) small employer health options; H.R. 2402, Woman's Health Insurance Fairness Act (Neal) gender rating for health insurance; H.R. 2413, Autism Treatment Acceleration Act (Doyle) coverage for autism spectrum disorders; H.R. 2427, Informed Consumer Choices in Health Care Act (DeLauro) federal standards for health insurance, consumer information; H.R. 2457, Right to a Second Medical Opinion Act (Davis) coverage of second opinions; H.R. 2609, Insurance Information Act (Kanjorski) Federal Office of Insurance Information; H.R. 2635, Gender Equity in Health Premiums Act (Sanchez) gender rating for health insurance; H.R. 2833, Medical Loss Ratios (Ellison) medical loss ratios; H.R. 2940, Women's Obstetrician and Gynecologist Medical Access Now Act (Davis) direct access to ob/gyns; H.R. 3200, Americas Affordable Health Choices Act (Dingell) government-run health plan, health insurance exchange, regulatory reform, health choices commissioner, insurance market reforms, individual coverage requirement, benefit packages, CLASS Act, medical loss ratios, premium assistance; H.R. 3217, Health Care Choice Act (Shadegg) national marketplace; H.R. 3584, Health Care Consumer Protection Act (Forbes) reinstatement of coverage upon payment of overdue premiums; H.R. 3590, Patient Protection and Affordable Care Act (Reid) government-run health plan, health insurance cooperatives, multi-state plans, insurance market reforms, health insurance exchanges, benefit packages, medical loss ratios, CLASS Act, regulatory reform, individual coverage requirement, premium assistance, federal rate review process, health care choice compacts, appeals procedures, disclosure requirements, high risk pool program, McCarran-Ferguson Act; H.R. 3596, Health Insurance Industry Antitrust Enforcement Act (Conyers) changes to McCarran-Ferguson Act; H.R.3681, Fairness in Health Insurance Act (cont.) H.R. 3961, Medicare Physician Payment Reform Act (Dingell) Medicare physician payment; H.R. 3962, Americas Affordable Health Choices Act (Dingell) government-run health plan, health insurance exchange, regulatory reform, health choices commissioner, insurance market reforms, individual coverage requirement, benefit packages, CLASS Act, medical loss ratios, premium assistance, federal rate review process, health care choice compacts, high risk pool program, McCarran-Ferguson Act; H.R. 4078, Long-Term Care Insurance Disclosure Act (Perriello) model disclosure form for long-term care insurance; S. 79, Healthy Businesses, Healthy Workers Reinsurance Act (Kerry) reinsurance; S. 93, Small Business Empowerment Act (Brown) small employer health options; S. 391, Healthy Americans Act (Wyden) comprehensive health reform; S. 442, Health Insurance Coverage Protection Act (Dorgan) lifetime benefit limits; S. 488, Access to Cancer Clinical Trials Act (Brown) clinical trials coverage mandate; S. 623, Pre-existing Condition Patient Protection Act (Rockefeller) preexisting condition exclusions; S. 643, Children's Health Protection Act (Lautenberg) preexisting condition exclusions for children; S. 688, Breast Cancer Patient Protection Act (Snowe) rescissions, hospital stays for breast cancer patients; S. 697, CLASS Act (Kennedy) national LTC program; S. 819, Autism Treatment Acceleration Act (Durbin) coverage for autism spectrum disorders; S. 969, Women's Health Insurance Fairness Act (Kerry) gender rating for health insurance; S. 979, SHOP Act (Durbin) small employer health options; S. 1050, Informed Consumer Choices in Health Care Act (Rockefeller) federal standards for health insurance, consumer information; S. 1149, Annual and Lifetime Health Care Limit Elimination Act (Rockefeller) annual and lifetime coverage limits; S. 1177, Confidence in Long-Term Care Insurance Act (Kohl) LTC consumer protections; S. 1235, Children's Access to Reconstructive Evaluation & Surgery Act (Landrieu) coverage mandate for treatment of a child's congenital or developmental deformity; S. 1258, Family Building Act (Gillibrand) coverage mandate for infertility treatments; S. 1459, Health Care Choice Act (DeMint) national marketplace; S. 1626, Long Term Care Insurance Integrity Act (Klobuchar) third party review of LTCI disputed claims; S. 1636, Long-Term Care Insurance Consumer Right-to-Know Act (Klobuchar) model disclosure forms for LTC insurance; S. 1679, Affordable Health Choices Act (Harkin) government-run health plan, insurance market reforms, health benefit gateways, benefit packages, medical loss ratios, CLASS Act, regulatory reform, individual coverage requirement, premium assistance; S. 1681, Health Insurance Industry Antitrust Enforcement Act (Leahy) changes to McCarran-Ferguson Act; S. 1730, Fairness in Health Insurance Act (Franken) medical loss ratios; S. 1796, Americas Healthy Future Act (Baucus) government-run health plan, health insurance cooperatives, health insurance exchange, insurance market reforms, individual coverage requirement, benefit packages, premium assistance, medical loss ratios, regulatory reform INS (Regulatory) Insurance regulatory reform; issues related to the coordination of private and public disability income benefits; disability risk management; issues relating to the coordination of benefits between private health insurance plans and Medicaid; Medigap claims processing and crossover fees; implementation of Medigap standardized plan offerings; Medigap carrier recoveries related to CMS fraud and abuse enforcement activities, and issues related to Medigap educational materials; implementation of the Mental Health Parity Act requirements; issues related to COBRA subsidy requirements, and issues related to genetic nondiscrimination.

Client expense: $2,540,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA), Treasury, Dept of

Issues related to the prevention and treatment of lung disease including the following legislation:HR 1619 Children's Health Protection Act of 2009; HR 716 Access to Cancer Clinical Trials Act; S. 488 Access to Cancer Clinical Trials Act; HR 1850 Quit Smoking for Life Act; S. 770 Medicare, Medicaid, and MCH Tobacco Cessation Promotion Act of 2009; S. 717 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act; HR 332 Lung Cancer Mortality Reduction Act of 2009; HR 2112 Lung Cancer Mortality Reduction Act of 2009; S. 670 Smoke Free Mothers and Babies Act of 2009; HR 3200: America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act; S.1796 Americas Healthy Future Act of 2009, HR 3590 The Patient Protection and Affordable Care Act; H.R. 3220 Medicare Home Oxygen Therapy Act of 2009; HR 3790 To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner; Issues related to asthma; Issues related to chronic obstructive pulmonary disease; Issues related to lung cancer; Issues related to tuberculosis; Issues related to durable medical equipment; Issues related to pulmonary rehabilitation services; Issues related to influenza; Issues related to tobacco cessation services;

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office

Issues related to the prevention and treatment of lung disease, including the following legislation: HR 1619 Children's Health Protection Act of 2009; S 643 Children's Health Protection Act of 2009; HR 716 Access to Cancer Clinical Trials Act; S. 488 Access to Cancer Clinical Trials Act; HR 1850 Quit Smoking for Life Act; S. 770 Medicare, Medicaid, and MCH Tobacco Cessation Promotion Act of 2009; S. 717 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act S. 332 Lung Cancer Mortality Reduction Act of 2009; HR 2112 Lung Cancer Mortality Reduction Act of 2009; S 670 Smoke Free Mothers and Babies Act of 2009; S.914 Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009; HR 1079 Pulmonary Fibrosis Research Enhancement Act; HR 2730 Student-to-School Nurse Ratio Improvement Act of 2009; HR 3293 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010; HR 3200: America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act; S.1796 Americas Healthy Future Act of 2009; HR 3590 The Patient Protection and Affordable Care Act; S. 1577 The Asthma Act; H.R. 3220 Medicare Home Oxygen Therapy Act of 2009; HR 2293 The Public Health Trade Advisory Committee Act; S. 1760 Family Asthma Act; HR 3754 Family Asthma Act; H.Res 919 Supporting the goals and ideals of Chronic Obstructive Pulmonary Disease Awareness Month; S. 2817 A bill to amend part D of title V of the Elementary and Secondary Education Act of 1965 to provide grants to schools for the development of asthma management plans and the purchase of asthma inhalers and spacers for emergency use, as necessary; P.L. 110-233, Genetic Information Nondescrimination Act; HR 3790 To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner; Issues related to asthma; Issues related to chronic obstructive pulmonary disease; Issues related to lung cancer; Issues related to tuberculosis; Issues related to nicotine drug delivery devices; Issues related to drug safety; Issues related to durable medical equipment; Issues related to pulmonary rehabilitation services; Issues related to influenza; Issues related to genetic non-discrimination;

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office

S. 488/H.R. 716 - Access to Cancer Clinical Trials Act of 2009; H.R. 1189 - Colorectal Cancer Prevention, Early Protection, and Treatment Act of 2009; H.R. 1330 - Colorectal Cancer Screening and Detection Coverage Act of 2009; H.R. 756/S. 660 - National Pain Policy Act of 2009; S. 497/H.R. 2043 - Nurse Education, Expansion, and Development Act of 2009; Health Reform; Health Workforce Shortage Issues; S. 623/H.R. 1558 - Preexisting Condition Exclusion Patient Protection Act of 2009; (Continued) S. 643/H.R. 1619 - Children's Health Protection Act of 2009; S. 688/H.R. 1691 - Breast Cancer Patient Protection Act; H.R. 2366 - Cancer Drug Coverage Parity Act; FDA Regulation of Opioids; H.R. 2115- Men and Familes Health Care Act; Health Care Reform; H.R. 3962 - Affordable Health Care for America Act; H.R. 3590 - Patient Protection and Affordable Care Act.

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office

H.R. 716, S.488 - Access to Cancer Clinical Trials Act H.R. 3200 - America's Affordable Health Choices Act of 2009 S. 1679 - Affordable Health Choices Act S. 1796 - America's Healthy Future Act of 2009 H.R. 3134 - Healthcare Innovation Zone Program Act of 2009 H.R. 3962 - Affordable Health Care for America Act H.R. 3590 - Patient Protection and Affordable Care Act

Client expense: $80,000 · Firm income: Not reported

Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE

Healthcare for cancer patients, C.W. Bill Young Transplantation Program, National Cord Blood Inventory, H.R. 1230, Bone Marrow Failure Disease Research and Treatment Act of 2009, S. 488, H.R. 716, Access to Cancer Clinical Trials Act of 2009, SGW 121 access to all health care bill, SRES 205/HCR 150 African American Bone Marrow Awareness Month, Americans Affordable Health Choices Act of 2009, American Healthy Future Act of 2009.

Client expense: $60,018 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Tax credits for Cord Blood donations-donor related expenses, HR 716, HR 1654, HR 1718

Client expense: $60,018 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Support for the Access to Cancer Clinical Trials Act of 2009 (S. 488, H.R. 716) to provide access to clinical trials for cancer patients. Support for health care reform provisions in the America's Healthy Future Act (H.R. 3200), the Patient Protection and Affordable Care Act (H.R. 3590), and the Affordable Health Choices Act (S. 1796) to reform health care through a combination of public and private approaches to cover medically necessary services; support review and development of national workforce strategy; support elimination of pre-existing condition limitations; support medical liability reform; support consumer protection from annual and lifetime insurance limits; provide funding for comparative effectiveness research; and support expanded access to and use of regular health assessments and preventive services, including early screening and detection. Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support for the development of domestic medical isotope production, specifically American Medical Isotope Production Act of 2009 (H.R. 3276). Letter to FDA supporting regulation to ensure the validity of in vitro diagnostic tests.

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE, Veterans Affairs, Dept of (VA)

S. 488/H.R. 716, Access to Cancer Clinical Trials Act, seeking cosponsors H.R. 1844, Comprehensive Cancer Care Improvement Act, seeking cosponsors H.R. 3590, The Patient Protection and Affordable Care Act/H.R Affordable Health Care for America Act, seeking support for a clinical trials amendment H.R. 3590, The Patient Protection and Affordable Care Act/H.R Affordable Health Care for America Act, seeking support for a prompt pay amendment.

Client expense: $38,684 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE